TDACU NASDAQ
Translational Development Acquisition Corp.
1W: -8.5%
1M: -8.5%
3M: -0.9%
YTD: +10.2%
1Y: +11.0%
$11.50
-0.61 (-5.04%)
Weekly Expected Move ±3.0%
$11
$11
$12
$12
$12
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
$0
-100.0% ▼
Operating Income
-$945K
-381.0% ▼
Net Income
$6M
+9059.7% ▲
EPS (Diluted)
$0.37
+2384.0% ▲
EBITDA
-$945K
-1230.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1.07T | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | -100.0% |
| Cost of Revenue | $0 | $0 | $320.9B | $0 |
| Gross Profit | $0 | $0 | $744.9B | $0 |
| Gross Margin | — | — | 69.9% | — |
| R&D Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $71K | $486K | $196K | $945K |
| Operating Expenses | $71K | $486K | $196K | $945K |
| Operating Income | -$71K | -$486K | -$196K | -$945K |
| Operating Margin | — | — | -0.0% | — |
| Interest Expense | $0 | $0 | $508.6B | $0 |
| Income Before Tax | -$71K | -$486K | -$71K | $6M |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$71K | -$486K | -$71K | $6M |
| Net Margin | — | — | -0.0% | — |
| EPS (Diluted) | $-0.02 | $-0.12 | $-0.02 | $0.37 |
| EBITDA | $0 | -$486K | -$71K | -$945K |
| Shares Outstanding | 4M | 4M | 4M | 17M |